Mobile App

Due to an increasing incidence of type 1 diabetes in France, Germany, Italy, Spain, and the UK and a steady incidence in the United States, which still has a growing population of children and adolescents, there will be an increase in the number of cases of type 1 diabetes in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK over the next ten years.

Features and benefits

* Gain insight to market potential, including a robust 10-year epidemiology forecast of type 1 diabetes incident cases.
* Understand the current burden of disease with type 1 diabetes prevalence estimate.

Highlights

Type 1 diabetes is a metabolic disorder which can cause serious illness and death if not managed properly with insulin administration. The only risk factor shown to be significantly associated with the risk of type 1 diabetes is genetics and several genes have been linked to the risk. This report estimates that there will be a marginal increase or steady incidence of cases of type 1 diabetes in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK) between 2010 and 2020. This report estimates that there are approximately 2.7 million prevalent cases of type 1 diabetes mellitus in those aged under 80 in the year 2010.

Your key questions answered

* Which are the most robust epidemiologic studies for type 1 diabetes incidence and prevalence data?
* How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
* How do changes in population structure or risk factors affect the trend in incident type 1 diabetes cases?

Key Chapters of The Report :

Executive Summary
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Diagnosis and testing for diabetes mellitus
GLOBAL VARIATION AND HISTORICAL TRENDS
Conflicting evidence for a global increase in type 1 diabetes mellitus incidence
RISK FACTORS
Genetics
Environment
Ethnicity
Gender
Age
EPIDEMIOLOGIC FORECASTING
Sources of epidemiologic data
Description of methods
US
Japan
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Incidence
Prevalence
DISCUSSION
Strengths and weaknesses of our epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
Datamonitor reports
APPENDIX A
Module methodology

Get more information about this report: Epidemiology : Type 1 Diabetes

Find Market Research Reports

Check our Company Profiles and Country Reports

Bharat Book Bureau
Email: sandhya@bharatbook.com
Tel: +91 22 27578668
Fax: +91 22 27579131